Twenty-four weeks of combined training in different environments, aquatic and land, in the type 2 diabetes management (Aquatic and Land Exercise for Diabetes -ALED): protocol of a randomized clinical trial

• Published in: Current controlled trials in cardiovascular medicine 2025-01, Vol.26 (1), p.12-14, Article 12
• Main Authors: Dos Santos Leonel, Larissa, Wolin, Ingrid Alessandra Victoria, Danielevicz, Angélica, Diesel, Mabel, Constantini, Marina Isolde, de Oliveira Junior, João Batista, Souza, Allana Andrade, Reichert, Thaís, Silveira-Rodrigues, João Gabriel, Soares, Danusa Dias, Ronsoni, Marcelo Fernando, Van De Sande Lee, Simone, Rafacho, Alex, Speretta, Guilherme Fleury Fina, Lottermann, Karla Siqueira, Bertoli, Josefina, Muller, Alexandre Pastoris, Gerage, Aline Mendes, de La Rocha Freitas, Cíntia, Delevatti, Rodrigo Sudatti
• Format: Article
• Language: English
• Subjects: Aerobics; Aged; Aged, 80 and over; Aquatic training; Blood pressure; Brazil; Clinical trials; Consent; Diabetes; Diabetes Mellitus, Type 2 - physiopathology; Diabetes Mellitus, Type 2 - therapy; Diabetes therapy; Exercise; Exercise Therapy - methods; Female; Glycated hemoglobin; Glycosylated hemoglobin; Health aspects; Hemoglobin; Humans; Hypertension; Inflammation; Insulin resistance; Intervention; Male; Measurement; Metabolism; Middle Aged; Muscle Strength; Physical fitness; Physiological aspects; Product development; Quality of Life; Randomized Controlled Trials as Topic; Resistance Training - methods; Single-Blind Method; Sleep; Strength training; Study Protocol; Time Factors; Treatment Outcome; Type 2 diabetes; Weight training
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-024-08660-2

Physical exercise is crucial in type 2 diabetes management (T2D), and training in the aquatic environment seems to be a promising alternative due to its physical properties and metabolic, functional, cardiovascular, and neuromuscular benefits. Research on combined training in aquatic and dry-land training environments is scarce, especially in long-term interventions. Thus, this study aims to investigate the effects of combined training in both environments on health outcomes related to the management of T2D patients. This is a randomized, unicentric, single-blinded, comparator clinical trial with two parallel arms. Participants with T2D, of both sexes, aged at 45 to 80 years old, will be randomized into two groups (aquatic combined training (AQUA) and dry-land combined training (LAND)), both performing combined aerobic and resistance training three times a week on alternate days for 24 weeks. Aerobic training will be performed using continuous and pyramidal methods, with linear exercise intensity and duration progression. Intensity will be prescribed by rated effort perception (Borg scale 6 to 20). Resistance training will be performed using exercise for the trunk, upper and lower limbs maximum speed, and target repetition zone in aquatic and dry-land environments, respectively, using multiple sets in a linear dosage progression. Before, at 12 weeks, and after the 24 weeks of training, biochemical analyses, functional capacity, maximum muscle strength, body composition assessments, cardiovascular measures, and the administration of questionnaires to assess mental, cognitive, sleep quality, and quality of life will be conducted. Throughout the 24 weeks, the training load date and acute capillary glucose and blood pressure measurements will also be conducted. The data will be analyzed using the SPSS (29.0) statistical package, using a significance level of 0.05. For intra- and inter-group comparisons, generalized estimating equations will be applied and analyzed by intention-to-treat and per-protocol adopting the Bonferroni post hoc test. The obtained results may provide insights to enhance understanding of the benefits of the aquatic and dry-land environment on various health outcomes, as well as acute aspects and safety considerations of the training. Moreover, this could support the development of intervention strategies to optimize the T2D management. Brazilian Clinical Trial Registry (ReBEC) RBR-10fwqmfy. Registered on April 16, 2024.